Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis

Clinical evidence demonstrates coadministration of tumour necrosis factor inhibitor (TNFi) agents and methotrexate (MTX) is more efficacious than administration of TNFi agents alone in patients with rheumatoid arthritis, leading to the perception that coadministration of MTX with all biologic agents...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Emery, Paul, Sebba, Anthony, Huizinga, Tom W J
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2013
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3841743/
https://ncbi.nlm.nih.gov/pubmed/23918035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-203485
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares